Prot #201501057: NU WU15S01: A Phase II Study of Pazopanib as Front-Line Therapy in Patients with Non-Resectable or Metastatic Soft Tissue Sarcomas Who Are Not Candidates for Chemotherapy

  • Agulnik, Mark (PD/PI)

Project: Research project

Project Details

StatusActive
Effective start/end date4/12/164/12/22

Funding

  • Washington University St. Louis (Prot #201501057)
  • GlaxoSmithKline LLC (Prot #201501057)